Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

14.68
-0.6900-4.49%
Volume:59.79K
Turnover:888.71K
Market Cap:212.51M
PE:0.13
High:15.67
Open:15.52
Low:14.19
Close:15.37
Loading ...
Jan 19, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2021

Major Issues Report

8-K - Current report
Jan 05, 2021

Major Issues Report

8-K - Current report
Nov 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 12, 2020

Major Issues Report

8-K - Current report
Sep 11, 2020

Major Issues Report

8-K - Current report
Aug 31, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 21, 2020

Major Issues Report

8-K - Current report
Aug 19, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 14, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 12, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 05, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 03, 2020

Correspondence

CORRESP [Cover] - Correspondence
Jul 28, 2020

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Aug 20, 2019

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 03, 2019

Correspondence

CORRESP [Cover] - Correspondence
Jun 03, 2019

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933